Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Antimicrobial compositions comprising pyroglutamic acid and optionally metal salts

A pyroglutamic acid, antimicrobial technology, applied in the field of antimicrobial composition, can solve the problem of not being able to provide residual activity or efficacy against pathogenic viruses and bacteria

Inactive Publication Date: 2003-04-16
PROCTER & GAMBLE CO
View PDF71 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, most of these products do not provide residual activity or efficacy against pathogenic viruses and bacteria on the area to which they are applied

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1-5

[0362] Composition (Wt.%)

Embodiment 1

[0363] Example 1 : Dissolve surfactant, pyroglutamic acid, pyroglutamic acid ethyl ester and metal salt complex in ethanol and about 5% water. The polymeric thickener was slowly sieved into the solution with stirring. After stirring the solution for about 2 hours, the pH was adjusted to 3.0 with acid / base. Add appropriate amount of water.

Embodiment 2

[0364] Example 2 : Add Sepigel to about 5% of water. An equal amount of ethanol was added, allowing the mixture to thicken between two ethanol additions. Add pyroglutamic acid and metal salts and allow to dissolve. Surfactants are added, pH is adjusted with acid / base, and water is added to make the product.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
flash pointaaaaaaaaaa
melting pointaaaaaaaaaa
boiling pointaaaaaaaaaa
Login to View More

Abstract

The present invention is for compositions and their methods for prevention and treatment of cold and influenza-like symptoms due to respiratory tract viral infections. These compounds and their method of application are effective in both preventing the onset of the symptoms of colds and influenza or significantly mitigating them if already afflicted with such symptoms.

Description

technical field [0001] The present invention relates to antimicrobial compositions that provide enhanced immediate and residual antiviral and antibacterial efficacy. In particular, the antimicrobial compositions of the present invention, when used, provide residual efficacy against Gram-negative bacteria, Gram-positive bacteria and viruses, fungi, and improved immediate reduction of pathogens not previously seen in the prior art Effect. Background of the invention [0002] Human health is affected by a variety of microorganisms. The colonization of these microorganisms in humans or mammals often leads to a variety of different disorders and diseases. Public awareness of such contamination has increased in recent years due to an increase in food poisoning, streptococcal infections, and the like. Therefore, public health authorities have advised the public to wash any areas that normally come into contact with infected surfaces such as body parts (e.g. handwashing), food (e...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/12A61K8/00A61K8/02A61K8/34A61K8/44A61K8/49A61K9/08A61K9/70A61K9/72A61K31/19A61K31/191A61K31/192A61K31/194A61K31/28A61K31/375A61K31/4015A61K33/06A61K33/24A61K33/244A61K33/245A61K33/26A61K33/30A61K33/34A61K47/04A61K47/10A61K47/12A61K47/18A61K47/22A61K47/24A61K47/32A61L2/16A61L2/18A61M11/00A61P11/02A61P31/04A61P31/12A61P31/16A61Q5/02A61Q17/00A61Q19/10C11D3/02C11D3/33C11D3/48D21H21/36D21H27/32
CPCD21H27/32A61Q17/005A61K8/0208A61K8/4913A61K31/28D21H21/36A61P11/00A61P11/02A61P31/04A61P31/12A61P31/16A61K2300/00A61K31/195
Inventor 金伯利·A·比德曼库尔特·G·克朗霍尔姆彼得·W·比尔斯杰弗里·M·摩根迈克尔·J·莫布利
Owner PROCTER & GAMBLE CO
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com